Stage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment (NCT02917629) | National Cancer Institute (NCI) | 2018-05-31 |
Track Stage 0 Oral Cavity Squamous Cell Carcinoma American Joint Committee on Cancer (AJCC) v6 and v7 automatically
Every clearance here is in the API, with alerts when new ones post.